| 15th Dec 2014 7:00 am |
RNS |
Initiation of fruquintinib Phase III study |
| 31st Oct 2014 7:03 am |
RNS |
Total Voting Rights |
| 7th Oct 2014 7:00 am |
RNS |
Drug R&D Update Briefing |
| 1st Oct 2014 7:00 am |
RNS |
Co-promotion agreement with Merck Serono |
| 19th Sep 2014 9:13 am |
RNS |
Holding(s) in Company |
| 21st Aug 2014 7:00 am |
RNS |
Patient enrolment in Phase II study completed |
| 13th Aug 2014 7:00 am |
RNS |
HMPL-004 Interim Analysis |
| 29th Jul 2014 7:00 am |
RNS |
Interim Results |
| 30th Jun 2014 7:00 am |
RNS |
Blocklisting Interim Review |
| 30th Jun 2014 7:00 am |
RNS |
Total Voting Rights |
| 26th Jun 2014 7:00 am |
RNS |
Notice of Results |
| 25th Jun 2014 7:00 am |
RNS |
Chi-Med Refinancing of Existing Loan Facility |
| 18th Jun 2014 7:00 am |
RNS |
Start of Phase I clinical trial with HMPL-523 |
| 5th Jun 2014 7:00 am |
RNS |
Initiation of fruquintinib Phase II study |
| 4th Jun 2014 1:52 pm |
RNS |
Director's Shareholding |
| 3rd Jun 2014 3:23 pm |
RNS |
Exercise of Options |
| 30th May 2014 9:10 am |
RNS |
Gains rights to six prescription drug products |
| 23rd May 2014 7:00 am |
RNS |
Initiation of Phase II Study in Renal Cancer |
| 22nd May 2014 7:00 am |
RNS |
Phase I data to be presented at ASCO |
| 8th May 2014 11:54 am |
RNS |
Result of AGM |
| 17th Apr 2014 7:00 am |
RNS |
Chi-Med and Sinopharm Deal Approved |
| 4th Apr 2014 7:00 am |
RNS |
Initiation of Phase II study in colorectal cancer |
| 4th Apr 2014 7:00 am |
RNS |
Presentations at the 2014 AACR Annual Meeting |
| 28th Mar 2014 7:00 am |
RNS |
2013 Annual Report and Notice of AGM |
| 18th Feb 2014 7:00 am |
RNS |
Final Results |
| 13th Feb 2014 8:14 am |
RNS |
Notification of Major Interest in Shares |
| 16th Jan 2014 7:00 am |
RNS |
Notice of Results |
| 30th Dec 2013 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 18th Dec 2013 9:02 am |
RNS |
Sinopharm distribution joint venture in China |
| 16th Oct 2013 11:58 am |
RNS |
Director/PDMR Shareholding |
| 9th Oct 2013 7:00 am |
RNS |
Payment From Janssen Pharmaceuticals |
| 9th Oct 2013 7:00 am |
RNS |
Lilly Deal for Fruquintinib |
| 9th Oct 2013 7:00 am |
RNS |
Analyst & Investor Briefing |
| 3rd Oct 2013 7:00 am |
RNS |
Analyst briefing on Chi-Med's R&D business |
| 13th Sep 2013 2:21 pm |
RNS |
Holding(s) in Company |
| 8th Aug 2013 12:05 pm |
RNS |
Director/PDMR Shareholding |
| 30th Jul 2013 7:00 am |
RNS |
Interim Results |
| 17th Jul 2013 7:00 am |
RNS |
Global Phase III HPML-004 maintenance study starts |
| 1st Jul 2013 7:00 am |
RNS |
Blocklisting Interim Review |
| 25th Jun 2013 7:00 am |
RNS |
Volitinib Phase I triggers US$5 million milestone |
